EUVIMEDEUVIMED entdecken
Crossref

Doxorubicin-Loaded Niosomal Transporters Demonstrate Enhanced Cytotoxicity Against Brain Cancer Cells: An In Vitro Study

Özge Çağlar Yıldırım

Türk Doğa ve Fen Dergisi · 30.03.2026 · 15 (1) · 174-181

DOI: 10.46810/tdfd.1623422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Türk Doğa ve Fen Dergisi, online erschienen am 30.03.2026. Verfasst von Özge Çağlar Yıldırım. Die Arbeit nennt 34 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study was the first to evaluate the anticancer activity of doxorubicin -loaded niosomes on human brain cancer cells. Niosomal drug delivery systems were formulated using the thin film hydration method, incorporating Tween 40 and cholesterol in different ratios. The mean particle size, polydispersity index and zeta potential of empty niosomes were measured to be 150 nm, 0.265 and -21.5 mV, respectively. The loading efficiency of doxorubicin into the niosomes reached an impressive 95%. For doxorubicin-loaded niosomes, the mean particle size, polydispersity index and zeta potential were determined to be 174 nm, 0.290 and -22.8 mV, respectively. The drug release profile was assessed by UV-vis spectroscopy and showed a cumulative doxorubicin release of 30.8% over 24 hours. The cytotoxicity of doxorubicin-loaded niosomes was tested on healthy dermal fibroblast cells using the3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and showed no significant toxicity after 24 hours exposure to various concentrations. Conversely, significant anticancer effects were observed in SHSY-5Y and U87-MG brain cancer cell lines treated with doxorubicin-loaded niosomes, as evidenced by a significant decrease in cell proliferation compared to controls. Notably, the niosomal doxorubicin formulation exhibited higher anticancer efficacy compared to free doxorubicin. These results highlight the potential of niosomal drug delivery systems as a promising strategy to enhance the therapeutic efficacy of doxorubicin while minimizing its off-target toxicity.

Zitieren

APA

Yıldırım, Ö. Ç. (2026). Doxorubicin-Loaded Niosomal Transporters Demonstrate Enhanced Cytotoxicity Against Brain Cancer Cells: An In Vitro Study. Türk Doğa ve Fen Dergisi, 15(1), 174-181. https://doi.org/10.46810/tdfd.1623422

Vancouver

Yıldırım ÖÇ. Doxorubicin-Loaded Niosomal Transporters Demonstrate Enhanced Cytotoxicity Against Brain Cancer Cells: An In Vitro Study. Türk Doğa ve Fen Dergisi. 2026;15(1):174-181. doi:10.46810/tdfd.1623422

BibTeX
@article{Yldrm2026,
  author = {Yıldırım, Özge Çağlar},
  title = {Doxorubicin-Loaded Niosomal Transporters Demonstrate Enhanced Cytotoxicity Against Brain Cancer Cells: An In Vitro Study},
  journal = {Türk Doğa ve Fen Dergisi},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {174--181},
  doi = {10.46810/tdfd.1623422}
}
Kostenlos starten →